Document Detail

Treatment and outcome of middle ear cancer.
MedLine Citation:
PMID:  24121777     Owner:  NLM     Status:  Publisher    
This study addressed the clinical characteristics, treatment, and outcome of middle ear cancer. A series of 33 patients with middle ear cancer were analyzed with survival, the primary outcome. Altogether, 25 patients underwent surgery with adjuvant radiotherapy, seven patients had surgery alone, and one patient had only radiotherapy. The patients were staged according to the Stell staging system. Among patients with T1/T2 cancers, five underwent lateral temporal bone resection (LTBR) and three underwent subtotal temporal bone resection (STBR). Among those with T3/Tx cancers, 11 underwent LTBR, and 13 had STBR. Of the total 33 patients, 18 died of their disease during follow-up. The overall 5-year survival rate was 37.4 %. The 5-year survival rates for patients with T1/T2 disease and T3/Tx disease were 85.7 and 22.0 %, respectively. There was a statistically significant difference in 5-year survival rates between the two groups using the log-rank test (P < 0.05). The 5-year survival rates after LTBR and STBR for the T3/Tx group were 15.2 and 30.8 % (P > 0.05), respectively, and those for the T1/T2 group were 100 and 66.7 % (P > 0.05), respectively. The 5-year survival rates for patients who underwent preoperative or postoperative radiotherapy were 38.9 and 40.4 %, respectively (P > 0.05). En bloc resection is favored in an effort to produce negative surgical margins for middle ear cancer. Adjunctive radiotherapy is used for advanced lesions.
Xianhao Jia; Qin Liang; Fanglu Chi
Related Documents :
24355207 - Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
22644517 - Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity r...
23108087 - Risk factors for survival after colorectal cancer resection.
25038877 - Leptomeningeal disease and breast cancer: the importance of tumor subtype.
11588907 - Pilot study of a specific dietary supplement in tumor-bearing mice and in stage iiib an...
1306607 - Locoregional control for esophageal carcinoma treated with irradiation following surgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-10-10
Journal Detail:
Title:  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery     Volume:  -     ISSN:  1434-4726     ISO Abbreviation:  Eur Arch Otorhinolaryngol     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-10-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002937     Medline TA:  Eur Arch Otorhinolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Otolaryngology, Eye Ear Nose and Throat Hospital, Fudan University, 83 Fenyang Road, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Allelic Diversity and Its Implications for the Rate of Adaptation.
Next Document:  The occurrence of molds in patients with chronic sinusitis.